USFDA concludes pre-approval, cGMP inspection at Bengaluru facilities of Syngene International

24 Feb 2025 Evaluate

The United States Food and Drug Administration (USFDA) has conducted a pre-approval and cGMP inspection covering commercial manufacturing activities for the US market at Syngene International’s Bengaluru facilities. The inspection conducted from February 10, 2025 to February 20, 2025. On conclusion of the inspection, the USFDA issued Form 483 with 5 observations. The Company will work closely with USFDA and remains committed to addressing these observations comprehensively within the stipulated time.

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.

Syngene Internation. Share Price

666.00 -10.50 (-1.55%)
13-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 666.00
Sagility India 42.01
AGS Transact Tech 12.69
Just Dial 818.70
Krystal Integrated 422.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...